Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 5.9 USD 0.85%
Market Cap: 339.2m USD
Have any thoughts about
Kamada Ltd?
Write Note

Kamada Ltd
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kamada Ltd
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Kamada Ltd
NASDAQ:KMDA
Other Liabilities
$52.4m
CAGR 3-Years
119%
CAGR 5-Years
113%
CAGR 10-Years
20%
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Other Liabilities
$2.5m
CAGR 3-Years
-5%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Other Liabilities
$121.9m
CAGR 3-Years
14%
CAGR 5-Years
135%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Other Liabilities
$178k
CAGR 3-Years
26%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Other Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pluri Inc
NASDAQ:PLUR
Other Liabilities
$5.6m
CAGR 3-Years
75%
CAGR 5-Years
20%
CAGR 10-Years
3%
No Stocks Found

Kamada Ltd
Glance View

Market Cap
339.1m USD
Industry
Biotechnology

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

KMDA Intrinsic Value
5.83 USD
Overvaluation 1%
Intrinsic Value
Price

See Also

What is Kamada Ltd's Other Liabilities?
Other Liabilities
52.4m USD

Based on the financial report for Sep 30, 2024, Kamada Ltd's Other Liabilities amounts to 52.4m USD.

What is Kamada Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
20%

Over the last year, the Other Liabilities growth was -8%. The average annual Other Liabilities growth rates for Kamada Ltd have been 119% over the past three years , 113% over the past five years , and 20% over the past ten years .

Back to Top